TrialNCT05717920Phase 2Completed
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)
Study sponsor: Aldeyra Therapeutics, Inc. · ALDX
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2023-11-21Actual
Enrollment · participants8Actual
Source updated2024-11-04Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.